Politics
ICE being investigate for non-consensual Neuralink testing on detainess
Scrutiny Deepens Under Trump's Choices
Who T is in My Had
(Source: Drey's Substack)
(Source: Drey's Substack)
Neuralink, founded by Musk to develop implantable brain–computer interfaces intended to restore mobility and treat neurological disorders, is already under federal investigation for potential violations of the Animal Welfare Act, as first reported by Reuters in 2022. That probe, led by the U.S. Department of Agriculture’s Inspector General, followed internal complaints that Musk’s demands for rapid progress had led to rushed, error-ridden animal tests and unnecessary suffering.
A New Series of Findings
In 2025, investigative journalist Drey, host of The Drey Dossier Channel, launched a new series titled “Who TF Is In My Head?” documenting what they describe as “dark corners” inside Neuralink’s expansion efforts. According to Drey, internal documents, procurement data, and federal contract records reveal patterns suggesting that Neuralink’s human-testing operations may be expanding outside official FDA-approved sites.
In one video, Drey highlighted that Musk announced plans in mid-2025 to scale from seven brain implants to roughly 1,000 by the end of 2026 — an unprecedented acceleration. “That’s about sixty surgeries per month,” Drey noted. “Given Neuralink’s existing infrastructure, it’s nearly impossible unless recruitment is happening through other channels.”
In 2025, investigative journalist Drey, host of The Drey Dossier Channel, launched a new series titled “Who TF Is In My Head?” documenting what they describe as “dark corners” inside Neuralink’s expansion efforts. According to Drey, internal documents, procurement data, and federal contract records reveal patterns suggesting that Neuralink’s human-testing operations may be expanding outside official FDA-approved sites.
In one video, Drey highlighted that Musk announced plans in mid-2025 to scale from seven brain implants to roughly 1,000 by the end of 2026 — an unprecedented acceleration. “That’s about sixty surgeries per month,” Drey noted. “Given Neuralink’s existing infrastructure, it’s nearly impossible unless recruitment is happening through other channels.”
The Geography Problem
The Drey Dossier’s analysis connects Neuralink’s two approved U.S. research centers — the Barrow Neurological Institute in Phoenix, Arizona, and the University of Miami — with ICE detention facilities located nearby. Between late 2024 and early 2025, three detainees reportedly died at Miami’s Krome Detention Facility, all presenting with neurological symptoms such as seizures and hemorrhages. One of them, Maksym Chernyak, 44, a Ukrainian refugee with no pre-existing conditions, died sixteen days after detention from a massive brain hemorrhage.
While no direct link to Neuralink has been established, the timing and proximity have prompted calls for an independent review.
Meanwhile, advocacy groups in Arizona reported that average time in solitary confinement at nearby ICE facilities rose 271% in 2025 — a duration Drey argues could conceal unmonitored medical procedures or memory gaps. “Thirty-eight days in isolation is enough for a person to question their own memory,” Drey said.
The Drey Dossier’s analysis connects Neuralink’s two approved U.S. research centers — the Barrow Neurological Institute in Phoenix, Arizona, and the University of Miami — with ICE detention facilities located nearby. Between late 2024 and early 2025, three detainees reportedly died at Miami’s Krome Detention Facility, all presenting with neurological symptoms such as seizures and hemorrhages. One of them, Maksym Chernyak, 44, a Ukrainian refugee with no pre-existing conditions, died sixteen days after detention from a massive brain hemorrhage.
While no direct link to Neuralink has been established, the timing and proximity have prompted calls for an independent review.
Meanwhile, advocacy groups in Arizona reported that average time in solitary confinement at nearby ICE facilities rose 271% in 2025 — a duration Drey argues could conceal unmonitored medical procedures or memory gaps. “Thirty-eight days in isolation is enough for a person to question their own memory,” Drey said.
The Honolulu Connection
Using federal contract data, The Drey Dossier uncovered a series of neurological surgery contracts routed through an obscure firm, NIR LLC, in Honolulu, Hawaii. The company, which has no online presence, was awarded Department of Defense contracts for neurological procedures at Tripler Army Medical Center — while listing its address at Straub Medical Center, a civilian hospital eight miles away.
Records also show Neuralink-linked personnel based in Honolulu, including a clinical project manager and a private equity investor whose firm lists Neuralink as part of its portfolio. Though Hawaii is not among Neuralink’s FDA-approved test sites, ICE began housing detainees at FDC Honolulu in early 2025, transferring individuals from Florida and Arizona — the same states where Neuralink operates.
“These overlapping patterns — medical contracts, Neuralink staff, new detention agreements — form a constellation that warrants serious scrutiny,” Drey stated.
Using federal contract data, The Drey Dossier uncovered a series of neurological surgery contracts routed through an obscure firm, NIR LLC, in Honolulu, Hawaii. The company, which has no online presence, was awarded Department of Defense contracts for neurological procedures at Tripler Army Medical Center — while listing its address at Straub Medical Center, a civilian hospital eight miles away.
Records also show Neuralink-linked personnel based in Honolulu, including a clinical project manager and a private equity investor whose firm lists Neuralink as part of its portfolio. Though Hawaii is not among Neuralink’s FDA-approved test sites, ICE began housing detainees at FDC Honolulu in early 2025, transferring individuals from Florida and Arizona — the same states where Neuralink operates.
“These overlapping patterns — medical contracts, Neuralink staff, new detention agreements — form a constellation that warrants serious scrutiny,” Drey stated.
Oversight Gaps and Political Ties
Further adding to concern, February 2025 marked the removal of twenty FDA officials from the Office of Neurological and Physical Medicine Devices — the very unit responsible for overseeing Neuralink’s trials. Around the same time, ICE officials publicly acknowledged working “frequently” with Musk’s Department of Government Efficiency (DOGE) initiative.
Experts consulted by The Drey Dossier argue that this coordination, combined with the FDA staffing cuts, weakened oversight just as Neuralink ramped up operations. “You eliminate the people who ask uncomfortable questions,” Drey observed. “That’s efficiency by design.”
Historical Parallels
Human-rights organizations following the case warn that the allegations, if confirmed, would recall past abuses such as the Tuskegee Syphilis Study and Guatemala experiments, in which vulnerable or detained populations were used for medical research without consent.
“The infrastructure for exploitation rarely looks like a lab — it looks like a bureaucracy,” Drey commented in one episode. “Detention centers, shell companies, missing paperwork — it’s all there, just folded into an interesting shape.”
Further adding to concern, February 2025 marked the removal of twenty FDA officials from the Office of Neurological and Physical Medicine Devices — the very unit responsible for overseeing Neuralink’s trials. Around the same time, ICE officials publicly acknowledged working “frequently” with Musk’s Department of Government Efficiency (DOGE) initiative.
Experts consulted by The Drey Dossier argue that this coordination, combined with the FDA staffing cuts, weakened oversight just as Neuralink ramped up operations. “You eliminate the people who ask uncomfortable questions,” Drey observed. “That’s efficiency by design.”
Historical Parallels
Human-rights organizations following the case warn that the allegations, if confirmed, would recall past abuses such as the Tuskegee Syphilis Study and Guatemala experiments, in which vulnerable or detained populations were used for medical research without consent.
“The infrastructure for exploitation rarely looks like a lab — it looks like a bureaucracy,” Drey commented in one episode. “Detention centers, shell companies, missing paperwork — it’s all there, just folded into an interesting shape.”
The Ongoing Inquiry
Independent investigators are now reviewing The Drey Dossier’s documentation, which includes federal procurement records, LinkedIn employment data, and witness statements. While no official enforcement action has been announced, several civil-rights attorneys have reportedly begun preparing Freedom of Information Act (FOIA) requests to trace contracts between Neuralink, ICE, and the Department of Defense.
“The evidence doesn’t yet prove illegal activity,” Drey cautioned. “But it paints a picture of a system capable of hiding it.”
As the investigation unfolds, the central question remains whether Neuralink’s race to commercialize its brain-computer interface has crossed ethical — or legal — boundaries.
Until regulators or Congress demand full transparency, much of what’s happening in the company’s expanding network of partnerships and facilities will remain buried in the data — and in the dark.
Independent investigators are now reviewing The Drey Dossier’s documentation, which includes federal procurement records, LinkedIn employment data, and witness statements. While no official enforcement action has been announced, several civil-rights attorneys have reportedly begun preparing Freedom of Information Act (FOIA) requests to trace contracts between Neuralink, ICE, and the Department of Defense.
“The evidence doesn’t yet prove illegal activity,” Drey cautioned. “But it paints a picture of a system capable of hiding it.”
As the investigation unfolds, the central question remains whether Neuralink’s race to commercialize its brain-computer interface has crossed ethical — or legal — boundaries.
Until regulators or Congress demand full transparency, much of what’s happening in the company’s expanding network of partnerships and facilities will remain buried in the data — and in the dark.
According to an ongoing investigation by American Independent Media, Elon Musk’s brain-implant company Neuralink, while promoted as a breakthrough medical innovation for treating neurological conditions, may have a darker experimental dimension. The report cites experts and whistleblowers who allege that Neuralink’s technology could be involved in covert population testing, with claims of mind manipulation, thought messaging, and psychological interference conducted without informed consent.
The investigation also references concerns over Musk’s reported dependence on ketamine, suggesting potential health consequences linked to long-term use. One source close to Musk’s circle claimed, “He’s not just using drugs — he’s developing them.”
Even more alarming are allegations that Musk may be operating a covert research facility testing microdosed substances on unwitting individuals, possibly using genetically modified mosquitoes to deliver these compounds while his surveillance network collects behavioral and neurological data.
The investigation also references concerns over Musk’s reported dependence on ketamine, suggesting potential health consequences linked to long-term use. One source close to Musk’s circle claimed, “He’s not just using drugs — he’s developing them.”
Even more alarming are allegations that Musk may be operating a covert research facility testing microdosed substances on unwitting individuals, possibly using genetically modified mosquitoes to deliver these compounds while his surveillance network collects behavioral and neurological data.
The American Independent Media report further points to the Palm Springs desert region as a potential testing ground. It also highlights alleged ties between Musk and Riverside County Sheriff Chad Bianco, who has faced prior scrutiny for human rights violations in local jails. Some sources claim Musk has offered financial backing to Bianco’s rumored gubernatorial ambitions in exchange for expanded access to vulnerable jail populations for unregulated drug and technology testing.
more information: https://https://thedreydossier.substack.com/
Liability for this article lies with the author, who also holds the copyright. Editorial content from USPA may be quoted on other websites as long as the quote comprises no more than 5% of the entire text, is marked as such and the source is named (via hyperlink).
